Apogee Therapeutics (APGE) Change in Account Payables (2022 - 2026)
Apogee Therapeutics' (APGE) quarterly Change in Account Payables came in at $16000.0 in Q1 2026, down 98.84% year-on-year from $1.4 million in Q1 2025, and down 98.11% on a QoQ basis from $845000.0 in Q4 2025.
Apogee Therapeutics (APGE) Change in Account Payables (2022 - 2026) Analysis & Trends
Apogee Therapeutics (APGE) has 5 years of Change in Account Payables data on file, last reported at $16000.0 in Q1 2026.
- On a quarterly basis, Change in Account Payables fell 98.84% year-over-year to $16000.0 in Q1 2026; TTM through Mar 2026 was -$1.2 million, a 34.95% increase from a year earlier, with the FY2025 full-year figure at $150000.0, up 113.99% from the prior year.
- Change in Account Payables for Q1 2026 stood at $16000.0, down from $845000.0 in the prior quarter.
- Over the last five years, Change in Account Payables for APGE reached as high as $9.9 million in Q2 2023 and fell as low as -$9.8 million in Q3 2023.
- Historically, Change in Account Payables has averaged $733.33 across 5 years, with a median of $477000.0 in 2023.
- Across the five-year window, Change in Account Payables slumped 805.57% in 2023 and jumped 352.62% in 2024, its largest moves.
- Year by year, Change in Account Payables stood at $382000.0 in 2022, then surged by 171.2% to $1.0 million in 2023, then sank by 210.52% to -$1.1 million in 2024, then jumped by 173.8% to $845000.0 in 2025, then plunged by 98.11% to $16000.0 in 2026.
- Per Business Quant data, the three most recent Change in Account Payables figures were $16000.0 in Q1 2026, $845000.0 in Q4 2025, and -$5.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Apogee Therapeutics | 9.35 Bn | 8.29 Bn | - | 16,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,000.00 |
| Mar 31, 2026 | 16,000.00 |
| Dec 31, 2025 | 845,000.00 |
| Dec 31, 2025 | 845,000.00 |
| Sep 30, 2025 | -5.30 Mn |
| Sep 30, 2025 | -5.30 Mn |
| Jun 30, 2025 | 3.23 Mn |
| Jun 30, 2025 | 3.23 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Mar 31, 2025 | 1.37 Mn |
| Dec 31, 2024 | -1.15 Mn |
| Dec 31, 2024 | -1.15 Mn |
| Sep 30, 2024 | -3.31 Mn |
| Sep 30, 2024 | -3.31 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Jun 30, 2024 | 1.23 Mn |
| Mar 31, 2024 | 2.16 Mn |
| Mar 31, 2024 | 2.16 Mn |
| Dec 31, 2023 | 1.04 Mn |
| Dec 31, 2023 | 1.04 Mn |